From Psychiatric News
November 7, 2008
Psychiatrists are told that they must assume responsibility for screening and monitoring severely mentally ill patients at high risk for diabetes, cardiovascular disease, and metabolic syndrome.
Studies of lab orders for patients receiving second-generation antipsychotic (SGA) medications reveal that few are getting screened or monitored for cardiovascular and metabolic risk factors, reported Elaine Morrato, Dr.P.H., at a symposium at APA’s Institute on Psychiatric Services last month in Chicago….
….children and adolescents who might benefit most from primary prevention of cardiovascular disease and metabolic syndrome are even less likely than adults to receive screening and monitoring.
“There is a disparity that continues to exist between guideline recommendationsfor cardiometabolic monitoring and screening and the monitoringthat actually exists in practice, with a gap between what psychiatristsare telling us in terms of their practice and what we are seeing whenwe look at lab claims for glucose and lipid testing,”
…..just 29 percent of the psychiatrists said they monitorlipid levels in all or some of their patients.
I can vouch that never once in my 20 year psych patient career was I ever asked to get my lipids or glucose tested, in spite of a 90lb weight gain. I will say my doctor was careful when I was on Lithium and then Depakote to get blood levels of those drugs as toxicity and death are possible on both of them.
Hallelujah! I’m not on anything that needs monitoring anymore and I’ve somehow managed to get out without diabetes or any risk factors for heart disease other than being fat. But that is thanks to my extremeley healthy lifestyle and LUCK. Bottom line, no matter how healthy one is in terms of diet and excercise these drugs can still make you fat, give you heart disease, diabetes, and kidney failure among other ailments and these diseases can all potentially kill you.